Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: fred hayes who wrote (3674)	12/2/2002 1:25:44 PM
From: Harold Engstrom	Read Replies (1) \| Respond to of 10345

Fred, All treatments for MS are totally insufficient - Avonex included. Antegren appears to be a step in the right direction - but still insufficient. About 8 years ago there was a new treatment for ulcers based on the discovery that a certain bacteria was responsible. Some heart ailments and cancers have been linked to or highly correlated with infections. People have assumed that MS is another disease with some similar cause. Consider that within 20 degrees of the equator, MS is extremely rare, while in colder climes it occurs regularly. Some people have theorized that gamma interferon is too prolific in MS sufferers and that taking beta causes the body to flush all interferons out thereby reducing gamma levels. No one has a clue yet. Avonex is safe for a few years and Antegren will be safe for years, too. Unfortunately.